Endocrine disrupting properties to be added for four phthalates in the Authorisation List

ECHA has submitted a recommendation to the European Commission to amend Authorisation List (Annex XIV of REACH) entries by adding the endocrine disrupting properties of four phthalates. Once the Commission decides on the amendment, some previously exempted uses will require authorisation.

ECHA has prepared a recommendation to amend the Authorisation List to include endocrine disrupting properties into the respective entries of: 

(*) bis(2-ethylhexyl) phthalate (DEHP) (EC 204-211-0, CAS 117-81-7)
(*) benzyl butyl phthalate (BBP) (EC 201-622-7, CAS 85-68-7)
(*) dibutyl phthalate (DBP) (EC 201-557-4, CAS 84-74-2)
(*) diisobutyl phthalate (DIBP) (EC 201-553-2, CAS 84-69-5).

They were identified as substances of very high concern (SVHCs) due to endocrine disrupting properties with effects on human health. DEHP was also identified for its effects on the environment. The Candidate List entries for these substances were updated accordingly in 2014 and 2017.

These four phthalates had already earlier been identified as SVHCs (in 2008 and 2009) and subsequently added to the Authorisation List in 2011 and 2012 due to their classification as toxic for reproduction.

A public consultation on the draft amendment recommendation was held between December 2018 and March 2019. A previous consultation on behalf of the European Commission on the same issue was held between June and August 2018. The Member State Committee (MSC) considered the comments received and adopted its opinion on 26 June 2019.

CONTINUE READING ON echa.europa.eu